NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: Phase II results

Authors

Eliot L. Friedman MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

6-2007

Published In/Presented At

R. R. McWilliams et al.,

NCCTG phase I/II trial (N9943) of gemcitabine and pemetrexed in patients with biliary tract or gallbladder carcinoma: Phase II results. JCO 25, 4578-4578(2007).

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Lehigh Valley Topper Cancer Institute

Document Type

Article